SPOTLIGHT -
Baltimore-Patients prescribed latanoprost (Xalatan, Pfizer Ophthalmics) continue therapy significantly longer than their counterparts using other prostaglandin-type drugs, according to the results of a population-based, retrospective cohort study.
Sean Donahue, MD, PhD, to become president of the American Association for Pediatric Ophthalmology and Strabismus
(EyePod) From idea to impact: Navigating ophthalmic innovation
Multiple companies announce data presentations at ARVO 2024
EyePod: Modifier Gene Therapy: What is it?
Eyenovia provides clinical, scientific update on FDA-approved products Mydcombi and clobetasol propionate ophthalmic suspension
Verana Health launches its Qdata Thyroid Eye Disease module